Gary E. Archer

Gary E. Archer publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Gary E. Archer sits on this spectrum.

Gary E. Archer D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Gary E. Archer sits on this spectrum.

Best Publications

• Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma

  John H. Sampson;Amy B Heimberger;Gary E. Archer;Kenneth D. Aldape

  912
  Citations

• Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma.

  Peter E. Fecci;Duane A. Mitchell;John F. Whitesides;Weihua Xie

  676
  Citations

• Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients

  Duane A. Mitchell;Kristen A. Batich;Michael D. Gunn;Min-Nung Huang

  572
  Citations

• Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma.

  Peter A. Humphrey;Albert J. Wong;Bert Vogelstein;Michael R. Zalutsky

  464
  Citations

• Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function.

  Peter E. Fecci;Hidenobu Ochiai;Duane A. Mitchell;Peter M. Grossi

  388
  Citations

• Progress Report of a Phase I Study of the Intracerebral Microinfusion of a Recombinant Chimeric Protein Composed of Transforming Growth Factor (TGF)-α and a Mutated form of the Pseudomonas Exotoxin Termed PE-38 (TP-38) for the Treatment of Malignant Brain Tumors

  John H. Sampson;Gamal Akabani;Gary E. Archer;Darell D. Bigner

  363
  Citations

• Mutant Epidermal Growth Factor Receptor Up-Regulates Molecular Effectors of Tumor Invasion

  Anita Lal;Chad A. Glazer;Holly M. Martinson;Henry S. Friedman

  359
  Citations

• An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme.

  John H. Sampson;Gary E. Archer;Duane A. Mitchell;Amy B. Heimberger

  334
  Citations

• Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination

  Kristen A. Batich;Elizabeth A. Reap;Gary E. Archer;Luis Sanchez-Perez

  301
  Citations

• Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system

  John H. Sampson;Gerald E. Archer;David M. Ashley;Herbert E. Fuchs

  300
  Citations

• Epidermal growth factor receptor VIII peptide vaccination is efficacious against established intracerebral tumors.

  Amy B. Heimberger;Laura E. Crotty;Gary E. Archer;Kenneth R. Hess

  288
  Citations

• The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target

  C J Wikstrand;C J Reist;G E Archer;M R Zalutsky

  253
  Citations

• Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors.

  John H. Sampson;Laura E. Crotty;Samson Lee;Gary E. Archer

  253
  Citations

• Brain Tumors in Mice Are Susceptible to Blockade of Epidermal Growth Factor Receptor (EGFR) with the Oral, Specific, EGFR-Tyrosine Kinase Inhibitor ZD1839 (Iressa)

  Amy B. Heimberger;Chris A. Learn;Gary E. Archer;Roger E. McLendon

  240
  Citations

• Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma

  John H. Sampson;Gary E. Archer;Duane A. Mitchell;Amy B. Heimberger

  213
  Citations

• Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant III contributes to the neoplastic phenotype of glioblastoma multiforme.

  Chris A. Learn;Tristan L. Hartzell;Carol J. Wikstrand;Gary E. Archer

  201
  Citations

• Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma

  Bryan D. Choi;Chien-Tsun Kuan;Mingqing Cai;Gary E. Archer

  173
  Citations

• EGFRvIII-Targeted Vaccination Therapy of Malignant Glioma

  Bryan D. Choi;Gary E. Archer;Duane A. Mitchell;Amy B. Heimberger

  167
  Citations

• A Novel Inhibitor of Signal Transducers And Activators Of Transcription 3 Activation Is Efficacious Against Established Central Nervous System Melanoma and Inhibits Regulatory T Cells

  Ling Yuan Kong;Mohamed K. Abou-Ghazal;Jun Wei;Arup Chakraborty

  166
  Citations

• Tumor-specific Anti-Epidermal Growth Factor Receptor Variant III Monoclonal Antibodies: Use of the Tyramine-Cellobiose Radioiodination Method Enhances Cellular Retention and Uptake in Tumor Xenografts

  Craig J. Reist;Gary E. Archer;Shekar N. Kurpad;Carol J. Wikstrand

  163
  Citations